ImmunityBio, Inc.

IBRX stock score: 51/100

$8.31 · -3.82% · Scored Oct 22, 2026

Technical
59
Fundamental
44
News
56

The reading

ImmunityBio (IBRX) scores 51 out of 100, which reads neutral, higher than 67% of Healthcare stocks and 47% of the 4,161 US stocks we score.

The composite is technicals and fundamentals weighted equally: technicals read 59, fundamentals 44.

Among the fundamentals, Price Target at 100 and Revenue Growth (Annual) at 100 score highest, while Earnings Profitability (Quarterly) at 0 weighs the most against it.

On the daily chart, trend-following indicators average 40 and contrarian oscillators 60.

News sentiment is neutral at 56; it is shown, not counted in the composite.

Since Jul 25, 2026 the composite has ranged from 51 to 59, and it is down 5 points over the period.

What’s driving the score

The strongest and weakest of the scorers that count toward IBRX’s composite. Each returns 0–100, higher is more bullish — including metrics where low is good, like P/E.

Fundamental

44

Pulling it up

  • Price Target100

    Price target score compares the current stock price to analyst consensus targets.

  • Revenue Growth (Annual)100

    Annual revenue growth tracks year-over-year sales expansion.

  • Institutional Ownership100

    Institutional ownership measures the percentage held by professional investors.

Holding it back

  • Earnings Profitability (Quarterly)0

    Earnings Profitability (Quarterly) measures recent profitability using trailing 12-month quarterly data.

  • Earnings Quality (Annual)0

    Earnings Quality (Annual) assesses absolute profitability independent of growth, measuring whether the company is profitable, its earnings yield (earnings/market cap), profit margins, and consistency.

  • EV/Revenue0

    EV/Revenue compares the whole company's value, debt included, with its sales.

37 weighted scorers; 4 had no data today and are left out rather than counted as zero.

Technical · daily

46

Pulling it up

  • 52-Week Change100

    The price change over the last 52 weeks.

  • S&P 500 52W Comparison100

    S&P 500 52-week comparison evaluates the stock's annual performance relative to the broader market.

  • Ichimoku Cloud98

    Ichimoku Cloud is a comprehensive indicator showing support/resistance, trend direction, and momentum.

Holding it back

  • Candlestick Patterns0

    Candlestick patterns recognize specific price formations that historically suggest continuation or reversal.

  • SMA 100

    Simple Moving Average (10-period) smooths price action over 10 periods.

  • VWAP0

    Volume Weighted Average Price (VWAP) shows the average price weighted by volume.

62 weighted scorers; 3 had no data today and are left out rather than counted as zero.

News · shown, not counted

Global News
56

Technical score by timeframe

ChartScoreWeight
Hourly351
Daily463
Weekly642
Monthly742
Quarterly722

Composite score, last 90 days

05010051Jul 25, 2026Oct 22, 2026Jul 25, 2026: 56Jul 26, 2026: 56Jul 27, 2026: 56Jul 28, 2026: 57Jul 29, 2026: 56Jul 30, 2026: 59Jul 31, 2026: 58Aug 2, 2026: 53Aug 3, 2026: 54Aug 5, 2026: 54Aug 6, 2026: 55Aug 7, 2026: 57Aug 8, 2026: 56Aug 9, 2026: 56Aug 10, 2026: 56Aug 11, 2026: 57Aug 12, 2026: 58Aug 13, 2026: 57Aug 14, 2026: 55Aug 15, 2026: 56Aug 16, 2026: 56Aug 17, 2026: 58Aug 18, 2026: 57Aug 19, 2026: 59Aug 20, 2026: 57Aug 22, 2026: 55Aug 23, 2026: 55Aug 24, 2026: 53Aug 25, 2026: 57Aug 26, 2026: 57Aug 27, 2026: 58Aug 28, 2026: 56Aug 29, 2026: 56Aug 30, 2026: 56Aug 31, 2026: 55Sep 1, 2026: 55Sep 2, 2026: 56Sep 3, 2026: 57Sep 4, 2026: 57Sep 5, 2026: 57Sep 6, 2026: 57Sep 7, 2026: 57Sep 8, 2026: 58Sep 9, 2026: 55Sep 10, 2026: 52Sep 11, 2026: 55Sep 12, 2026: 55Sep 13, 2026: 55Sep 14, 2026: 57Sep 15, 2026: 55Sep 16, 2026: 54Sep 17, 2026: 57Sep 18, 2026: 57Sep 19, 2026: 57Sep 20, 2026: 57Sep 21, 2026: 57Sep 22, 2026: 58Sep 23, 2026: 56Sep 24, 2026: 56Sep 25, 2026: 56Sep 26, 2026: 56Sep 27, 2026: 56Sep 28, 2026: 57Sep 29, 2026: 57Sep 30, 2026: 58Oct 1, 2026: 58Oct 2, 2026: 59Oct 3, 2026: 59Oct 4, 2026: 59Oct 5, 2026: 59Oct 6, 2026: 57Oct 7, 2026: 57Oct 8, 2026: 58Oct 9, 2026: 59Oct 10, 2026: 59Oct 11, 2026: 59Oct 12, 2026: 58Oct 13, 2026: 57Oct 14, 2026: 58Oct 15, 2026: 57Oct 16, 2026: 55Oct 17, 2026: 55Oct 18, 2026: 55Oct 19, 2026: 53Oct 20, 2026: 53Oct 21, 2026: 53Oct 22, 2026: 51
Show the daily numbers
DateComposite
Oct 22, 202651
Oct 21, 202653
Oct 20, 202653
Oct 19, 202653
Oct 18, 202655
Oct 17, 202655
Oct 16, 202655
Oct 15, 202657
Oct 14, 202658
Oct 13, 202657
Oct 12, 202658
Oct 11, 202659
Oct 10, 202659
Oct 9, 202659
Oct 8, 202658
Oct 7, 202657
Oct 6, 202657
Oct 5, 202659
Oct 4, 202659
Oct 3, 202659
Oct 2, 202659
Oct 1, 202658
Sep 30, 202658
Sep 29, 202657
Sep 28, 202657
Sep 27, 202656
Sep 26, 202656
Sep 25, 202656
Sep 24, 202656
Sep 23, 202656
Sep 22, 202658
Sep 21, 202657
Sep 20, 202657
Sep 19, 202657
Sep 18, 202657
Sep 17, 202657
Sep 16, 202654
Sep 15, 202655
Sep 14, 202657
Sep 13, 202655
Sep 12, 202655
Sep 11, 202655
Sep 10, 202652
Sep 9, 202655
Sep 8, 202658
Sep 7, 202657
Sep 6, 202657
Sep 5, 202657
Sep 4, 202657
Sep 3, 202657
Sep 2, 202656
Sep 1, 202655
Aug 31, 202655
Aug 30, 202656
Aug 29, 202656
Aug 28, 202656
Aug 27, 202658
Aug 26, 202657
Aug 25, 202657
Aug 24, 202653
Aug 23, 202655
Aug 22, 202655
Aug 20, 202657
Aug 19, 202659
Aug 18, 202657
Aug 17, 202658
Aug 16, 202656
Aug 15, 202656
Aug 14, 202655
Aug 13, 202657
Aug 12, 202658
Aug 11, 202657
Aug 10, 202656
Aug 9, 202656
Aug 8, 202656
Aug 7, 202657
Aug 6, 202655
Aug 5, 202654
Aug 3, 202654
Aug 2, 202653
Jul 31, 202658
Jul 30, 202659
Jul 29, 202656
Jul 28, 202657
Jul 27, 202656
Jul 26, 202656
Jul 25, 202656

Key facts

Market cap
$8.8B
Sector
Healthcare
Industry
Biotechnology
Beta
0.03
Risk grade (1–10)
8
Next earnings
Nov 3, 2026

Biotechnology peers

CompanyMarket capScore
KYMR Kymera Therapeutics$9.1B50
PTGX Protagonist Therapeutics$9.0B57
TWST Twist Bioscience$9.0B49
CAI Caris Life Sciences$9.0B57
CYTK Cytokinetics$8.7B44
SYRE Spyre Therapeutics$8.6B52

Questions

What is IBRX's stock score today?

IBRX scores 51/100 (Neutral) as of Oct 22, 2026: technical 59, fundamental 44, and news sentiment 56, which is shown but not counted. Scores are recomputed every night.

Is IBRX a buy?

The score is not a buy or sell recommendation. A 51 says the technical and fundamental signals we measure lean neutral today, relative to every other stock scored the same way. Use the breakdown above to see why, and treat it as a starting point for your own research.

How is the IBRX score calculated?

99 weighted scorers feed it today: 37 fundamental, scored against Healthcare ranges, and 62 technical on the daily chart, with 5 timeframes blended into the technical total. Every scorer returns 0–100; missing data is left out, never counted as zero.

Scores are information, not investment advice. Computed from Yahoo Finance, Finnhub and Alpha Vantage data; technical indicators via TA-Lib. Past scores do not predict future returns.